ELOINE Film-coated tablet Ref.[50614] Active ingredients: 17 alpha-Ethinylestradiol Drospirenone

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2021  Publisher: Bayer plc, 400 South Oak Way, Reading, RG2 6AD

Product name and form

ELOINE 0.02 mg / 3 mg film coated tablets.

Pharmaceutical Form

Film-coated tablets.

The active tablets are light pink, round with convex faces; one side marked with the letters “DS” in a regular hexagon.

The placebo tablets are white, round with convex faces, one side marked with the letters “DP” in a regular hexagon.

Qualitative and quantitative composition

24 light pink film-coated tablets: Each film-coated tablet contains 0.020 mg ethinylestradiol (as betadex clathrate) and 3 mg drospirenone.

Excipient with known effect: lactose 46 mg (as lactose monohydrate 48.18 mg)

4 white placebo (inactive) film-coated tablets: The tablet does not contain active substances.

Excipient with known effect: lactose 22 mg (as lactose monohydrate 23.21 mg)

For the full list of excipients, see section 6.1.

Active Ingredient Description
17 alpha-Ethinylestradiol

Ethinylestradiol is chemically and biologically identical to endogenous human oestradiol. It substitutes for the loss of estrogen production in menopausal women, and alleviates menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy.

Drospirenone

Drospirenone is a progestogen. In a therapeutic dosage, drospirenone also possesses antiandrogenic and mild antimineralocorticoid properties. It has no estrogenic, glucocorticoid and antiglucocorticoid activity. This gives drospirenone a pharmacological profile closely resembling the natural hormone progesterone.

List of Excipients
Active film-coated tablets (light pink): Placebo film-coated tablets (white)
Tablet core:
Lactose monohydrate
Maize starch
Magnesium stearate (E470b)
Lactose monohydrate
Microcrystalline cellulose
Magnesium stearate (E470b)
Tablet film-coating:
Hypromellose (E464)
Talc (E553b)
Titanium dioxide (E171)
Iron oxide red (E172)
Hypromellose (E464)
Talc (E553b)
Titanium dioxide (E171)

Pack sizes and marketing

Transparent PVC/Aluminium blister in a folding box.

Pack sizes:

28 tablets
3 × 28 tablets
6 × 28 tablets

Each blister contains 24 light pink active film-coated tablets and 4 white placebo film-coated tablets.

Not all pack sizes may be marketed.

Marketing authorization holder

Bayer plc, 400 South Oak Way, Reading, RG2 6AD

Marketing authorization dates and numbers

PL 00010/0575

26 June 2008 / 13 June 2012

Drugs

Drug Countries
ELOINE Austria, United Kingdom, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.